Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CB Scientific, Inc. stock logo
CBSC
CB Scientific
$0.05
-16.2%
$0.04
$0.02
$0.15
$9.77M1.1966,721 shs15,000 shs
RZLTD
Rezolute
$3.83
-1.5%
$3.23
$16.00
$24.05
$32.24M4.634,788 shs1.17 million shs
AngioSoma, Inc. stock logo
SOAN
AngioSoma
$0.00
$0.00
$0.09
$32.57M-0.466.74 million shs5 shs
VolitionRx Limited stock logo
VNRX
VolitionRx
$0.49
+1.5%
$0.50
$0.40
$0.90
$50.66M1184,965 shs70,780 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CB Scientific, Inc. stock logo
CBSC
CB Scientific
-16.25%+11.86%+42.86%-37.11%-28.57%
RZLTD
Rezolute
-1.54%-3.04%-0.52%-8.37%+7.58%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00%0.00%0.00%-33.33%-71.43%
VolitionRx Limited stock logo
VNRX
VolitionRx
+1.49%-3.87%+6.20%-23.08%-27.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
RZLTD
Rezolute
N/AN/AN/AN/AN/AN/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/AN/AN/AN/A
VolitionRx Limited stock logo
VNRX
VolitionRx
1.7432 of 5 stars
3.30.00.00.02.02.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CB Scientific, Inc. stock logo
CBSC
CB Scientific
0.00
N/AN/AN/A
RZLTD
Rezolute
0.00
N/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00
N/AN/AN/A
VolitionRx Limited stock logo
VNRX
VolitionRx
2.67
Moderate Buy$3.75662.66% Upside

Current Analyst Ratings Breakdown

Latest CBSC, RZLTD, VNRX, and SOAN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
4/8/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$2.50 ➝ $2.50
3/31/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
3/20/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
3/12/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
3/4/2025
VolitionRx Limited stock logo
VNRX
VolitionRx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CB Scientific, Inc. stock logo
CBSC
CB Scientific
$140K58.46N/AN/AN/A
RZLTD
Rezolute
N/AN/AN/AN/A$1.24 per shareN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/AN/A
VolitionRx Limited stock logo
VNRX
VolitionRx
$1.31M38.72N/AN/A($0.11) per share-4.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/AN/A0.00N/AN/AN/AN/AN/A
RZLTD
Rezolute
-$20.33MN/A0.00N/AN/A-153.46%-111.71%N/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
-$540KN/A0.00N/AN/AN/AN/A-1,245.34%N/A
VolitionRx Limited stock logo
VNRX
VolitionRx
-$35.32M-$0.27N/AN/A-2,321.14%N/A-163.39%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/AN/AN/AN/AN/A
RZLTD
Rezolute
N/AN/AN/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/A
VolitionRx Limited stock logo
VNRX
VolitionRx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/AN/AN/A
RZLTD
Rezolute
N/A
3.26
3.26
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
0.29
0.29
VolitionRx Limited stock logo
VNRX
VolitionRx
N/A
0.22
0.22

Institutional Ownership

CompanyInstitutional Ownership
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/A
RZLTD
Rezolute
N/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.02%
VolitionRx Limited stock logo
VNRX
VolitionRx
8.09%

Insider Ownership

CompanyInsider Ownership
CB Scientific, Inc. stock logo
CBSC
CB Scientific
N/A
RZLTD
Rezolute
4.60%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
VolitionRx Limited stock logo
VNRX
VolitionRx
10.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
CB Scientific, Inc. stock logo
CBSC
CB Scientific
5163.67 millionN/ANot Optionable
RZLTD
Rezolute
238.42 millionN/ANot Optionable
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A476.83 millionN/ANot Optionable
VolitionRx Limited stock logo
VNRX
VolitionRx
80103.02 million80.80 millionOptionable

Recent News About These Companies

VolitionRx initiated with a Buy at H.C. Wainwright

New MarketBeat Followers Over Time

Media Sentiment Over Time

CB Scientific stock logo

CB Scientific OTCMKTS:CBSC

$0.05 -0.01 (-16.25%)
As of 05/28/2025 02:13 PM Eastern

CB Scientific, Inc., through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Rezolute OTCMKTS:RZLTD

$3.83 -0.06 (-1.54%)
As of 05/27/2025

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

AngioSoma stock logo

AngioSoma OTCMKTS:SOAN

AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.

VolitionRx stock logo

VolitionRx NYSE:VNRX

$0.49 +0.01 (+1.49%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$0.49 +0.00 (+0.06%)
As of 05/28/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.